Clinical Report: Cellular Analysis of Synovial Fluid in LORA and PMR
Overview
This study investigates the synovial fluid cellular profiles in late-onset rheumatoid arthritis (LORA) and polymyalgia rheumatica (PMR).
Background
Late-onset rheumatoid arthritis (LORA) is increasingly prevalent among older adults, presenting unique challenges in diagnosis and management due to its distinct phenotype and the presence of comorbidities. Polymyalgia rheumatica (PMR) shares similar symptoms with LORA, complicating differential diagnosis.
Data Highlights
No numerical data or trial results were provided in the source material.
Key Findings
Late-onset rheumatoid arthritis (LORA) is defined as RA with onset at age 60 or older.
ACPA-negative LORA and PMR can present with similar symptoms, complicating diagnosis.
Synovial fluid analysis may provide more relevant inflammatory profiles compared to systemic biomarkers.
The study included 21 East Asian patients, categorized into ACPA-positive LORA, ACPA-negative LORA, and PMR.
High-dimensional cytometry was utilized to analyze immune cell profiles in synovial fluid.
Clinical Implications
Clinicians should consider synovial fluid analysis in the diagnostic process for older patients with inflammatory arthritis.
Conclusion
This study focuses on synovial fluid analysis in distinguishing between late-onset rheumatoid arthritis and polymyalgia rheumatica.
Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.
